357 related articles for article (PubMed ID: 26182979)
1. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
[TBL] [Abstract][Full Text] [Related]
2. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
[TBL] [Abstract][Full Text] [Related]
3. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
[TBL] [Abstract][Full Text] [Related]
4. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results.
Horger M; Weisel K; Horger W; Mroue A; Fenchel M; Lichy M
AJR Am J Roentgenol; 2011 Jun; 196(6):W790-5. PubMed ID: 21606271
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
Lacognata C; Crimì F; Guolo A; Varin C; De March E; Vio S; Ponzoni A; Barilà G; Lico A; Branca A; De Biasi E; Gherlinzoni F; Scapin V; Bissoli E; Berno T; Zambello R
Clin Radiol; 2017 Oct; 72(10):850-857. PubMed ID: 28587715
[TBL] [Abstract][Full Text] [Related]
6. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
[TBL] [Abstract][Full Text] [Related]
7. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
[TBL] [Abstract][Full Text] [Related]
8. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
9. Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging.
Horger M; Claussen C; Kramer U; Fenchel M; Lichy M; Kaufmann S
Eur J Radiol; 2014 Sep; 83(9):1655-64. PubMed ID: 24972451
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Diffuse Bone Marrow Infiltration Pattern in Monoclonal Plasma Cell Diseases by Quantitative Whole-body Magnetic Resonance Imaging.
Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Zhang S; Lin L
Acad Radiol; 2022 Apr; 29(4):490-500. PubMed ID: 34362664
[TBL] [Abstract][Full Text] [Related]
11. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
Zhang Y; Xiong X; Fu Z; Dai H; Yao F; Liu D; Deng S; Hu C
Eur J Radiol; 2019 Nov; 120():108695. PubMed ID: 31589995
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
Wu X; Nerisho S; Dastidar P; Ryymin P; Järvenpää R; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
NMR Biomed; 2013 Sep; 26(9):1186-94. PubMed ID: 23483722
[TBL] [Abstract][Full Text] [Related]
13. Intravoxel Incoherent Motion Diffusion-weighted Imaging of Multiple Myeloma Lesions: Correlation with Whole-Body Dynamic Contrast Agent-enhanced MR Imaging.
Bourillon C; Rahmouni A; Lin C; Belhadj K; Beaussart P; Vignaud A; Zerbib P; Pigneur F; Cuenod CA; Bessalem H; Cavet M; Boutekadjirt A; Haioun C; Luciani A
Radiology; 2015 Dec; 277(3):773-83. PubMed ID: 26131910
[TBL] [Abstract][Full Text] [Related]
14. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
Yamada A; Araki Y; Tanaka Y; Otsuki S; Yamada A; Moriyama M; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Furuya N; Fujimoto H; Okabe S; Gotoh M; Suzuki K; Saito K; Gotoh A
PLoS One; 2021; 16(7):e0253025. PubMed ID: 34242226
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
Squillaci E; Bolacchi F; Altobelli S; Franceschini L; Bergamini A; Cantonetti M; Simonetti G
Acta Radiol; 2015 Jun; 56(6):733-8. PubMed ID: 24973257
[TBL] [Abstract][Full Text] [Related]
16. Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.
Wennmann M; Neher P; Stanczyk N; Kahl KC; Kächele J; Weru V; Hielscher T; Grözinger M; Chmelik J; Zhang KS; Bauer F; Nonnenmacher T; Debic M; Sauer S; Rotkopf LT; Jauch A; Schlamp K; Mai EK; Weinhold N; Afat S; Horger M; Goldschmidt H; Schlemmer HP; Weber TF; Delorme S; Kurz FT; Maier-Hein K
Invest Radiol; 2023 Apr; 58(4):273-282. PubMed ID: 36256790
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
[TBL] [Abstract][Full Text] [Related]
18. Integrated Shimming Improves Lesion Detection in Whole-Body Diffusion-Weighted Examinations of Patients With Plasma Disorder at 3 T.
Zhang H; Xue H; Alto S; Hui L; Kannengiesser S; Berthold K; Jin Z
Invest Radiol; 2016 May; 51(5):297-305. PubMed ID: 26704452
[TBL] [Abstract][Full Text] [Related]
19. Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma.
Giles SL; Messiou C; Collins DJ; Morgan VA; Simpkin CJ; West S; Davies FE; Morgan GJ; deSouza NM
Radiology; 2014 Jun; 271(3):785-94. PubMed ID: 24475858
[TBL] [Abstract][Full Text] [Related]
20. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
Sommer G; Klarhöfer M; Lenz C; Scheffler K; Bongartz G; Winter L
Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
